ZNF394

gene
On this page

Also known as ZKSCAN14FLJ12298ZSCAN46

Summary

ZNF394 (zinc finger protein 394, HGNC:18832) is a protein-coding gene on chromosome 7q22.1, encoding Zinc finger protein 394 (Q53GI3). May be involved in transcriptional regulation.

The protein encoded by this gene is a zinc finger protein that inhibits the transcription of mitogen-activated protein kinase signaling pathways. The encoded protein may be involved in cardiac function.

Source: NCBI Gene 84124 — RefSeq curated summary.

At a glance

  • GWAS associations: 3
  • Clinical variants (ClinVar): 116 total
  • MANE Select transcript: NM_032164

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:18832
Approved symbolZNF394
Namezinc finger protein 394
Location7q22.1
Locus typegene with protein product
StatusApproved
AliasesZKSCAN14, FLJ12298, ZSCAN46
Ensembl geneENSG00000160908
Ensembl biotypeprotein_coding
OMIM619300
Entrez84124

Gene structure

Transcript identifiers

Ensembl transcripts: 13 — 7 protein_coding, 3 protein_coding_CDS_not_defined, 3 retained_intron

ENST00000337673, ENST00000394177, ENST00000426306, ENST00000462024, ENST00000464401, ENST00000481881, ENST00000485576, ENST00000651061, ENST00000651364, ENST00000926066, ENST00000970609, ENST00000970610, ENST00000970611

RefSeq mRNA: 2 — MANE Select: NM_032164 NM_001345967, NM_032164

CCDS: CCDS5666, CCDS87524

Canonical transcript exons

ENST00000337673 — 3 exons

ExonStartEnd
ENSE000017974659949324099494631
ENSE000035698129949871699498842
ENSE000036607749949963899500281

Expression profiles

Bgee: expression breadth ubiquitous, 266 present calls, max score 92.44.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 11.9570 / max 193.0262, expressed in 1775 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
8510811.95701775

Top tissues by expression

282 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
mononuclear cellCL:000084292.44gold quality
monocyteCL:000057692.42gold quality
bloodUBERON:000017892.36gold quality
leukocyteCL:000073892.22gold quality
bone marrowUBERON:000237191.93gold quality
granulocyteCL:000009491.57gold quality
bone marrow cellCL:000209291.51gold quality
calcaneal tendonUBERON:000370190.94gold quality
diaphragmUBERON:000110389.58silver quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099188.25gold quality
sural nerveUBERON:001548887.92gold quality
tendonUBERON:000004387.58gold quality
mucosa of urinary bladderUBERON:000125987.58gold quality
palpebral conjunctivaUBERON:000181286.93gold quality
spleenUBERON:000210686.31gold quality
parotid glandUBERON:000183185.84gold quality
blood vessel layerUBERON:000479785.13gold quality
lower esophagus mucosaUBERON:003583485.11gold quality
skin of abdomenUBERON:000141684.98gold quality
small intestine Peyer’s patchUBERON:000345484.85gold quality
left uterine tubeUBERON:000130384.76gold quality
hindlimb stylopod muscleUBERON:000425284.74gold quality
lymph nodeUBERON:000002984.73gold quality
tonsilUBERON:000237284.71gold quality
mucosa of stomachUBERON:000119984.65gold quality
left ovaryUBERON:000211984.41gold quality
amniotic fluidUBERON:000017384.40gold quality
small intestineUBERON:000210884.37gold quality
popliteal arteryUBERON:000225084.24gold quality
tibial arteryUBERON:000761084.24gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes5.06

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

12 targeting ZNF394, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-6778-3P99.9667.292693
HSA-MIR-153-5P99.8973.866317
HSA-MIR-469899.8471.414303
HSA-MIR-2681-5P99.7567.641655
HSA-MIR-494-3P99.7071.452795
HSA-MIR-6832-5P99.5864.821132
HSA-MIR-504-3P99.3067.181745
HSA-MIR-7151-3P99.0469.722370
HSA-MIR-4763-5P98.7563.89854
HSA-MIR-6742-3P97.9564.501490
HSA-MIR-27A-5P97.0165.63528
HSA-MIR-4695-3P96.7167.21836

Literature-anchored findings (GeneRIF, showing 1)

  • Overexpression of ZNF394 in the cell inhibits the transcriptional activities of c-Jun and AP-1 reporters. (PMID:15249231)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusZkscan14ENSMUSG00000029627
rattus_norvegicusAtp5mfENSRNOG00000027049

Paralogs (30): ZNF263 (ENSG00000006194), ZNF213 (ENSG00000085644), ZNF500 (ENSG00000103199), ZKSCAN1 (ENSG00000106261), ZNF205 (ENSG00000122386), ZSCAN9 (ENSG00000137185), PGBD1 (ENSG00000137338), ZNF215 (ENSG00000149054), ZSCAN12 (ENSG00000158691), ZNF75A (ENSG00000162086), ZSCAN21 (ENSG00000166529), ZNF232 (ENSG00000167840), ZNF24 (ENSG00000172466), ZNF449 (ENSG00000173275), ZSCAN4 (ENSG00000180532), ZSCAN22 (ENSG00000182318), ZNF75D (ENSG00000186376), ZNF396 (ENSG00000186496), ZNF397 (ENSG00000186812), ZSCAN30 (ENSG00000186814), ZKSCAN4 (ENSG00000187626), ZSCAN23 (ENSG00000187987), ZKSCAN3 (ENSG00000189298), ZSCAN16 (ENSG00000196812), ZSCAN25 (ENSG00000197037), ZSCAN26 (ENSG00000197062), ZNF165 (ENSG00000197279), ZKSCAN8 (ENSG00000198315), ZSCAN31 (ENSG00000235109), ZNF853 (ENSG00000236609)

Protein

Protein identifiers

Zinc finger protein 394Q53GI3 (reviewed: Q53GI3)

Alternative names: Zinc finger protein with KRAB and SCAN domains 14

All UniProt accessions (1): Q53GI3

UniProt curated annotations — full annotation on UniProt →

Function. May be involved in transcriptional regulation.

Subcellular location. Nucleus.

Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.

Isoforms (2)

UniProt IDNamesCanonical?
Q53GI3-11yes
Q53GI3-32

RefSeq proteins (2): NP_001332896, NP_115540* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001909KRABDomain
IPR003309SCAN_domDomain
IPR013087Znf_C2H2_typeDomain
IPR036051KRAB_dom_sfHomologous_superfamily
IPR036236Znf_C2H2_sfHomologous_superfamily
IPR038269SCAN_sfHomologous_superfamily

Pfam: PF00096, PF01352, PF02023

UniProt features (28 total): zinc finger region 7, cross-link 6, region of interest 3, sequence conflict 3, domain 2, compositionally biased region 2, splice variant 2, chain 1, modified residue 1, sequence variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q53GI3-F162.010.06

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (7): 12, 40, 203, 228, 254, 282, 443

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-212436Generic Transcription Pathway

MSigDB gene sets: 149 (showing top): GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP, GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP, DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN, TSENG_IRS1_TARGETS_DN, GNF2_DDX5, GNF2_PTPRC, MARSON_BOUND_BY_FOXP3_UNSTIMULATED, SCGGAAGY_ELK1_02, GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, MTOR_UP.N4.V1_DN, PDGF_UP.V1_UP, HOXA9_DN.V1_UP, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY

GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)

GO Molecular Function (7): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872), sequence-specific double-stranded DNA binding (GO:1990837)

GO Cellular Component (1): nucleus (GO:0005634)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
RNA Polymerase II Transcription1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
RNA polymerase II transcription regulatory region sequence-specific DNA binding2
regulation of DNA-templated transcription1
transcription by RNA polymerase II1
DNA-templated transcription1
regulation of gene expression1
regulation of RNA biosynthetic process1
cis-regulatory region sequence-specific DNA binding1
chromatin1
DNA-binding transcription factor activity1
regulation of transcription by RNA polymerase II1
transition metal ion binding1
nucleic acid binding1
binding1
cation binding1
double-stranded DNA binding1
sequence-specific DNA binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

600 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZNF394ARHGAP11BQ3KRB8461
ZNF394CMC2Q9NRP2452
ZNF394A0A087WTG0A0A087WTG0447
ZNF394NBPF26B4DH59447
ZNF394ARHGAP11AQ6P4F7445
ZNF394DUSP22Q9NRW4437
ZNF394USP19O94966418
ZNF394TCAF1Q9Y4C2407
ZNF394PTPN20Q4JDL3404
ZNF394JHYQ6NUN7403
ZNF394SCML1Q9UN30402
ZNF394GABPAQ06546398
ZNF394BEND2Q8NDZ0398
ZNF394ANKRD65E5RJM6397
ZNF394NEK4P51957371
ZNF394C1orf53Q5VUE5371

IntAct

35 interactions, top by confidence:

ABTypeScore
ZNF394SCAND1psi-mi:“MI:0914”(association)0.740
SCAND1ZNF394psi-mi:“MI:0915”(physical association)0.740
ZNF394CLK2psi-mi:“MI:0915”(physical association)0.560
CCNDBP1ZNF394psi-mi:“MI:0915”(physical association)0.560
CLK2ZNF394psi-mi:“MI:0915”(physical association)0.560
ZNF394CCNDBP1psi-mi:“MI:0915”(physical association)0.560
ZNF394ZBTB47psi-mi:“MI:0915”(physical association)0.560
RNPS1ZNF394psi-mi:“MI:0915”(physical association)0.560
ZNF394psi-mi:“MI:0915”(physical association)0.560
ZSCAN32ZNF197psi-mi:“MI:0914”(association)0.530
ZNF397ZNF197psi-mi:“MI:0914”(association)0.530
ZSCAN20ZNF197psi-mi:“MI:0914”(association)0.350
Mpsi-mi:“MI:0914”(association)0.350
ZBTB47ZNF394psi-mi:“MI:0915”(physical association)0.000
SCAND1ZNF394psi-mi:“MI:0915”(physical association)0.000
ZNF394SCAND1psi-mi:“MI:0915”(physical association)0.000
RNPS1ZNF394psi-mi:“MI:0915”(physical association)0.000
ZNF394psi-mi:“MI:0915”(physical association)0.000

BioGRID (21): ZNF394 (Two-hybrid), ZNF394 (Two-hybrid), ZNF394 (Affinity Capture-MS), ZNF394 (Affinity Capture-MS), ZNF394 (Affinity Capture-MS), ZNF394 (Affinity Capture-MS), ZNF394 (Affinity Capture-MS), CTNNBL1 (Affinity Capture-MS), ZNF394 (Affinity Capture-MS), ZNF394 (Affinity Capture-MS), SCAND1 (Affinity Capture-MS), ZNF394 (Affinity Capture-MS), ZNF394 (Two-hybrid), ZNF394 (Two-hybrid), SCAND1 (Two-hybrid)

ESM2 similar proteins: A1YEP8, A1YEV9, A1YFW2, A1YG26, A1YG48, A1YG60, A2T6E3, A2T6V8, A2T712, A2T736, A2T7D2, A2T7F4, A2T7L7, A2T812, A6QNZ0, O14709, O15535, O43296, O43309, P10073, P17023, P17097, P49910, Q07231, Q12901, Q15776, Q16670, Q1LZ87, Q3MJ62, Q53GI3, Q571J5, Q5JNZ3, Q5RAE6, Q5RBX0, Q5RCD9, Q5RJ54, Q7Z7L9, Q86W11, Q8IZ26, Q8NF99

Diamond homologs: A1YEP8, A1YEQ3, A1YEV9, A1YFW2, A1YFW6, A1YG26, A1YG48, A1YG60, A1YGJ4, A1YGK6, A2T6E3, A2T6V8, A2T6W2, A2T712, A2T736, A2T7D2, A2T7D7, A2T7F2, A2T7F4, A2T7L7, A2T812, A6QNZ0, A6QPT6, B2KFW1, O14709, O14771, O14978, O15535, O43309, O60304, O95125, P10073, P17022, P17028, P17029, P17040, P28698, P49910, P51815, P59923

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

116 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance111
Likely benign2
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1089 predictions. Top by Δscore:

VariantEffectΔscore
7:99476401:A:AGacceptor_gain1.0000
7:99476402:G:GGacceptor_gain1.0000
7:99479771:G:GTdonor_gain1.0000
7:99479772:A:Tdonor_gain1.0000
7:99494629:AACC:Aacceptor_loss1.0000
7:99494630:ACCT:Aacceptor_loss1.0000
7:99494632:C:Aacceptor_loss1.0000
7:99494633:T:Gacceptor_loss1.0000
7:99498714:A:ACdonor_gain1.0000
7:99498715:C:CCdonor_gain1.0000
7:99498715:CT:Cdonor_gain1.0000
7:99498715:CTCGG:Cdonor_gain1.0000
7:99498838:ATCCC:Aacceptor_gain1.0000
7:99498839:TCCC:Tacceptor_gain1.0000
7:99498840:CCC:Cacceptor_gain1.0000
7:99498840:CCCC:Cacceptor_gain1.0000
7:99498841:CC:Cacceptor_gain1.0000
7:99498841:CCC:Cacceptor_gain1.0000
7:99498841:CCCT:Cacceptor_loss1.0000
7:99498842:CC:Cacceptor_gain1.0000
7:99498842:CCTGG:Cacceptor_loss1.0000
7:99498843:C:CCacceptor_gain1.0000
7:99498843:CTGGA:Cacceptor_loss1.0000
7:99498844:T:Cacceptor_loss1.0000
7:99499634:TCAC:Tdonor_loss1.0000
7:99499636:A:ACdonor_gain1.0000
7:99499637:C:CCdonor_gain1.0000
7:99499637:C:CGdonor_loss1.0000
7:99504731:GAG:Gdonor_gain1.0000
7:99476398:TCCA:Tacceptor_loss0.9900

AlphaMissense

3724 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
7:99493613:A:CF534L0.998
7:99493613:A:TF534L0.998
7:99493615:A:GF534L0.998
7:99493697:G:CF506L0.998
7:99493697:G:TF506L0.998
7:99493699:A:GF506L0.998
7:99493946:G:CF423L0.998
7:99493946:G:TF423L0.998
7:99493948:A:GF423L0.998
7:99494030:G:CF395L0.998
7:99494030:G:TF395L0.998
7:99494032:A:GF395L0.998
7:99493781:G:CF478L0.997
7:99493781:G:TF478L0.997
7:99493783:A:GF478L0.997
7:99493670:G:CH515Q0.996
7:99493670:G:TH515Q0.996
7:99493764:A:GL484P0.996
7:99493929:A:GL429P0.996
7:99494114:G:CF367L0.996
7:99494114:G:TF367L0.996
7:99494116:A:GF367L0.996
7:99493658:G:CH519Q0.995
7:99493658:G:TH519Q0.995
7:99493668:T:GQ516P0.995
7:99493672:G:CH515D0.995
7:99493680:A:GL512P0.995
7:99493698:A:GF506S0.995
7:99494003:G:CH404Q0.995
7:99494003:G:TH404Q0.995

dbSNP variants (sampled 300 via entrez): RS1000067207 (7:99496379 C>T), RS1000078532 (7:99489575 T>C), RS1000243877 (7:99502019 T>C,G), RS1000298523 (7:99495733 G>A), RS1000415466 (7:99496072 T>C), RS1000799410 (7:99491247 A>G), RS1000911617 (7:99489931 G>T), RS1001030208 (7:99497684 T>C), RS1001083502 (7:99490994 T>C), RS1001376030 (7:99494606 T>A,C), RS1001428344 (7:99494785 A>G), RS1001497581 (7:99495887 G>T), RS1001801298 (7:99492922 C>T), RS1001990582 (7:99499316 C>T), RS1002057189 (7:99500314 G>A,C)

Disease associations

OMIM: gene MIM:619300 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

3 associations (top):

StudyTraitp-value
GCST004730_2Facial emotion recognition (sad faces)3.000000e-06
GCST008667_7Smoking status (heavy vs never)8.000000e-08
GCST90000047_140Age at first sexual intercourse2.000000e-15

EFO canonical traits (3, from GWAS)

EFO IDTrait name
EFO:0008329facial emotion recognition measurement
EFO:0006527smoking status measurement
EFO:0009749age at first sexual intercourse measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

42 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Doxorubicindecreases expression, decreases response to substance2
Tobacco Smoke Pollutionincreases expression2
Cadmium Chlorideincreases expression2
aristolochic acid Iincreases expression1
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamidedecreases expression1
TAK-243increases sumoylation1
methylmercuric chloridedecreases expression1
triphenyl phosphateaffects expression1
geraniolincreases expression1
sodium arseniteincreases expression1
cobaltous chlorideincreases expression1
butyraldehydeincreases expression1
cupric oxideincreases expression1
di-n-butylphosphoric acidaffects expression1
erucylphospho-N,N,N-trimethylpropylammoniumincreases expression1
abrineincreases expression1
elesclomolincreases expression, decreases reaction1
(4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II)decreases expression1
PCI 5002affects cotreatment, increases expression1
4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acidincreases expression1
Resveratrolaffects cotreatment, increases expression1
Temozolomidedecreases expression1
Acetylcysteinedecreases reaction, increases expression1
Air Pollutantsaffects expression, increases abundance1
Atrazinedecreases expression1
Benzo(a)pyreneincreases expression1
Gasolineaffects cotreatment, increases abundance, increases expression1
Methyl Methanesulfonateincreases expression1
Ozoneaffects expression, increases abundance1
Plant Extractsaffects cotreatment, increases expression1

Cellosaurus cell lines

1 cell lines: 1 transformed cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_XW40HEK293 eGFP-ZNF394Transformed cell lineFemale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.